Literature DB >> 9768838

Regulation of class I MHC gene expression in the developing and mature CNS by neural activity.

R A Corriveau1, G S Huh, C J Shatz.   

Abstract

To elucidate molecular mechanisms underlying activity-dependent synaptic remodeling in the developing mammalian visual system, we screened for genes whose expression in the lateral geniculate nucleus (LGN) is regulated by spontaneously generated action potentials present prior to vision. Activity blockade did not alter expression in the LGN of 32 known genes. Differential mRNA display, however, revealed a decrease in mRNAs encoding class I major histocompatibility complex antigens (class I MHC). Postnatally, visually driven activity can regulate class I MHC in the LGN during the final remodeling of retinal ganglion cell axon terminals. Moreover, in the mature hippocampus, class I MHC mRNA levels are increased by kainic acid-induced seizures. Normal expression of class I MHC mRNA is correlated with times and regions of synaptic plasticity, and immunohistochemistry confirms that class I MHC is present in specific subsets of CNS neurons. Finally, beta2-microglobulin, a cosubunit of class I MHC, and CD3zeta, a component of a receptor complex for class I MHC, are also expressed by CNS neurons. These observations indicate that class I MHC molecules, classically thought to mediate cell-cell interactions exclusively in immune function, may play a novel role in neuronal signaling and activity-dependent changes in synaptic connectivity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9768838     DOI: 10.1016/s0896-6273(00)80562-0

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  191 in total

1.  Dynamic regulation of cpg15 during activity-dependent synaptic development in the mammalian visual system.

Authors:  R A Corriveau; C J Shatz; E Nedivi
Journal:  J Neurosci       Date:  1999-09-15       Impact factor: 6.167

Review 2.  Molecular analysis of developmental plasticity in neocortex.

Authors:  E Nedivi
Journal:  J Neurobiol       Date:  1999-10

3.  Functional requirement for class I MHC in CNS development and plasticity.

Authors:  G S Huh; L M Boulanger; H Du; P A Riquelme; T M Brotz; C J Shatz
Journal:  Science       Date:  2000-12-15       Impact factor: 47.728

4.  Transcriptional analysis in the brain: trophin-induced hippocampal synaptic plasticity.

Authors:  Janet Alder; Smita Thakker-Varia; Ira B Black
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

5.  Expression of T cell receptor beta locus in central nervous system neurons.

Authors:  Josh Syken; Carla J Shatz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205

Review 6.  Future trends in neurovirology: neuronal survival during virus infection and analysis of virus-specific T cells in central nervous system tissues.

Authors:  Michael B A Oldstone
Journal:  J Neurovirol       Date:  2004-08       Impact factor: 2.643

Review 7.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

8.  MHC class I molecules are present both pre- and postsynaptically in the visual cortex during postnatal development and in adulthood.

Authors:  Leigh A Needleman; Xiao-Bo Liu; Faten El-Sabeawy; Edward G Jones; A Kimberley McAllister
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-13       Impact factor: 11.205

Review 9.  Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity.

Authors:  Dimitris N Xanthos; Jürgen Sandkühler
Journal:  Nat Rev Neurosci       Date:  2013-11-27       Impact factor: 34.870

10.  Characterisation of RT1-E2, a multigenic family of highly conserved rat non-classical MHC class I molecules initially identified in cells from immunoprivileged sites.

Authors:  Pierre Lau; Claire Amadou; Hélène Brun; Virginie Rouillon; Fiona McLaren; Anne-France Le Rolle; Margaret Graham; Geoffrey W Butcher; Etienne Joly
Journal:  BMC Immunol       Date:  2003-07-01       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.